Antitumor antibiotic compound
US4582639A · kind A · utility
8Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 1984 |
| Grant date | Apr 15, 1986 |
| Priority date | — |
| Expiry date | Jun 18, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new cyclic depsipeptide antitumor antibiotic designated herein as sandramycin is produced by fermentation of a new microorganism, Nocardioides sp. strain C49,009, ATCC 39419. Sandramycin possesses antibacterial activity and inhibits the growth of tumors in experimental animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.